Xavier Fontana

1.3k total citations
36 papers, 1.0k citations indexed

About

Xavier Fontana is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Xavier Fontana has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Oncology. Recurrent topics in Xavier Fontana's work include Neurogenesis and neuroplasticity mechanisms (9 papers), Axon Guidance and Neuronal Signaling (7 papers) and Nerve injury and regeneration (6 papers). Xavier Fontana is often cited by papers focused on Neurogenesis and neuroplasticity mechanisms (9 papers), Axon Guidance and Neuronal Signaling (7 papers) and Nerve injury and regeneration (6 papers). Xavier Fontana collaborates with scholars based in France, Spain and United Kingdom. Xavier Fontana's co-authors include José Antonio del Rı́o, Eduardo Soriano, Gennadij Raivich, Mariya Hristova, Axel Behrens, Clive Da Costa, Laura Thei, Milan Makwana, Smriti Patodia and G. Milano and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Xavier Fontana

36 papers receiving 1.0k citations

Peers

Xavier Fontana
Jane P. Ko United States
Raymond Rothstein United States
GD Yancopoulos United States
Richard C. Krueger United States
Jane P. Ko United States
Xavier Fontana
Citations per year, relative to Xavier Fontana Xavier Fontana (= 1×) peers Jane P. Ko

Countries citing papers authored by Xavier Fontana

Since Specialization
Citations

This map shows the geographic impact of Xavier Fontana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Fontana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Fontana more than expected).

Fields of papers citing papers by Xavier Fontana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Fontana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Fontana. The network helps show where Xavier Fontana may publish in the future.

Co-authorship network of co-authors of Xavier Fontana

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Fontana. A scholar is included among the top collaborators of Xavier Fontana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Fontana. Xavier Fontana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosenberg, Laura H., Anne-Laure Cattin, Xavier Fontana, et al.. (2018). HDAC3 Regulates the Transition to the Homeostatic Myelinating Schwann Cell State. Cell Reports. 25(10). 2755–2765.e5. 28 indexed citations
2.
Hristova, Mariya, Eridan Rocha‐Ferreira, Xavier Fontana, et al.. (2015). Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) reduces neonatal hypoxic‐ischaemic brain damage. Journal of Neurochemistry. 136(5). 981–994. 60 indexed citations
3.
Müller, Christina, et al.. (2015). SncRNA715 Inhibits Schwann Cell Myelin Basic Protein Synthesis. PLoS ONE. 10(8). e0136900–e0136900. 6 indexed citations
4.
Bribián, Ana, Xavier Fontana, Franc Llorens, et al.. (2012). Role of the Cellular Prion Protein in Oligodendrocyte Precursor Cell Proliferation and Differentiation in the Developing and Adult Mouse CNS. PLoS ONE. 7(4). e33872–e33872. 46 indexed citations
5.
Doyen, J., Antoîne Italiano, R. Largillier, et al.. (2009). Aromatase inhibition in male breast cancer patients: biological and clinical implications. Annals of Oncology. 21(6). 1243–1245. 65 indexed citations
6.
Burgaya, Ferran, Xavier Fontana, Albert Martı́nez, et al.. (2006). Semaphorin 6C leads to GSK-3-dependent growth cone collapse and redistributes after entorhino-hippocampal axotomy. Molecular and Cellular Neuroscience. 33(3). 321–334. 15 indexed citations
7.
Ureña, Jesús M., Anna La Torre, Albert Martı́nez, et al.. (2005). Expression, synaptic localization, and developmental regulation of Ack1/Pyk1, a cytoplasmic tyrosine kinase highly expressed in the developing and adult brain. The Journal of Comparative Neurology. 490(2). 119–132. 20 indexed citations
8.
Mingorance, Ana, Xavier Fontana, Eduardo Soriano, & José Antonio del Rı́o. (2005). Overexpression of myelin-associated glycoprotein after axotomy of the perforant pathway. Molecular and Cellular Neuroscience. 29(3). 471–483. 21 indexed citations
9.
Étienne-Grimaldi, Marie-Christine, Sandrine Pereira, Nicolas Magné, et al.. (2005). Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Annals of Oncology. 16(6). 934–941. 59 indexed citations
10.
Fontana, Xavier, Juan Nácher, Eduardo Soriano, & José Antonio del Rı́o. (2005). Cell Proliferation in the Adult Hippocampal Formation of Rodents and its Modulation by Entorhinal and Fimbria–Fornix Afferents. Cerebral Cortex. 16(3). 301–312. 27 indexed citations
11.
Fontana, Xavier, et al.. (2004). Bcl-2 overexpression does not promote axonal regeneration of the entorhino-hippocampal connections in vitro after axotomy. Brain Research. 1020(1-2). 204–209. 5 indexed citations
12.
Mingorance, Ana, Xavier Fontana, Ferran Burgaya, et al.. (2004). Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Molecular and Cellular Neuroscience. 26(1). 34–49. 94 indexed citations
13.
Fontana, Xavier, et al.. (1998). Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 403(1-2). 45–53. 19 indexed citations
14.
Fontana, Xavier, et al.. (1995). C-erb-B2 gene amplification and serum level of c-erb-B2 oncoprotein at primary breast cancer diagnosis.. PubMed. 14(5B). 2099–104. 19 indexed citations
15.
Fontana, Xavier, et al.. (1994). [Study of mdm2 gene amplification in primary breast tumors].. PubMed. 81(7). 587–92. 10 indexed citations
16.
Forni, M, Jean‐Pierre Armand, Xavier Fontana, et al.. (1993). Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients. European Journal of Cancer. 29(7). 983–988. 14 indexed citations
17.
Fontana, Xavier, O. Dassonville, J Vallicioni, et al.. (1993). Sedimentation rate and serum thymidine kinase activity: Prognostic factors in squamous cell head and neck cancer. Head & Neck. 15(5). 425–432. 6 indexed citations
18.
Fontana, Xavier, et al.. (1991). Assessment of “squamous cell carcinoma antigen” (SCC) as a marker of epidermoid carcinoma of the anal canal. Diseases of the Colon & Rectum. 34(2). 126–131. 12 indexed citations
19.
Namer, Moïse, A. Ramaioli, Xavier Fontana, et al.. (1991). Prognostic value of total cathepsin D in breast tumors. Breast Cancer Research and Treatment. 19(2). 85–93. 50 indexed citations
20.
Herait, Patrice, Jean‐Pierre Armand, Mohamed Benahmed, et al.. (1989). Phase II study of mitozolomide (M & B 39,565) in head and neck cancer. Medical Oncology and Tumor Pharmacotherapy. 6(4). 267–269. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026